Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American PathologistsBusiness Wire • 08/25/21
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with SeerBusiness Wire • 06/17/21
Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody TestBusiness Wire • 06/15/21
First Patient Enrolled in Biodesix and Addario Lung Cancer Medical Institute Study Aiming to Predict Patient Survival Using a Blood-based BiomarkerPRNewsWire • 05/26/21
Biodesix, Inc. (BDSX) CEO Scott Hutton on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/21
Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround TimeBusiness Wire • 04/28/21
Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch PlansBusiness Wire • 04/26/21
Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule ManagementBusiness Wire • 04/22/21
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC PatientsBusiness Wire • 04/10/21
Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer PatientsBusiness Wire • 04/06/21
Biodesix to Report Fourth Quarter and Fiscal 2020 Financial Results on March 16, 2021Business Wire • 03/09/21
Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen SchoolsBusiness Wire • 02/16/21